Centogene N.V. Common Shares is a leading global provider of genetic diagnostics for rare diseases. With a focus on precision medicine, the company combines genomic data with clinical information to enable better diagnoses and personalized treatments. Its state-of-the-art laboratories and extensive disease database make Centogene a valuable partner for researchers, healthcare professionals, and patients seeking innovative solutions in the field of genetic testing.
